Galderma Research & Development
Records under this name other than the patents Galderma Research & Development holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 51 patents it holds.
Back to Galderma Research & Development
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D727,727 | Sliding overcap for dispensing container Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D734,153 | Closure for a container Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D758,048 | Garment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,186,358 | Combination therapy for treating or preventing an inflammatory skin disorder Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,861,631 | Methods and compositions for safe and effective treatment of erythema Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D816,498 | Foam pump dispenser Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,807,726 | Method of Crosslinking Glycosaminoglycans Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,125,400 | Method for the Diagnosis of Rosacea Formerly held Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,853,275 | Concurrent Therapy Regime/Regimen for the Treatment of Acne Related Diseases Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 10,067,144 | Antibodies Against Human Sodium Channel Nav 1.9 Formerly held Lapsed on the fee record Ended Sep 4, 2026 · Low confidence | Lapsed on the fee record | Ended Sep 4, 2026 | Low confidence |